1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Mp0420: new trials by email Literature Review of Mp0420 trials Research Report on Mp0420
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and PK of Ensovibep (MP0420 - a New Candidate With Potential for Treatment of COVID-19) Ensovibep, Placebo - COVID-19 | Phase 1 | Terminated | Molecular Partners AG | 53 | 2020-11-18 | 2022-03-18 |
COVID-19 (1)
United Kingdom (1)